BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:1009-1031. [PMID: 11139352 DOI: 10.1053/bega.2000.0144] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Saleh MI, Melhim SB, Al-Ramadhani HM, Alzubiedi S. Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients. Eur J Drug Metab Pharmacokinet 2019;44:31-42. [PMID: 29948848 DOI: 10.1007/s13318-018-0490-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review. J Clin Transl Hepatol 2020;8:184-91. [PMID: 32832399 DOI: 10.14218/JCTH.2020.00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kalambokis G, Tsianos EV. Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med Hypotheses. 2011;76:105-109. [PMID: 20832949 DOI: 10.1016/j.mehy.2010.08.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
4 Mejias M, Garcia-Pras E, Gallego J, Mendez R, Bosch J, Fernandez M. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. J Hepatol. 2010;52:529-539. [PMID: 20206401 DOI: 10.1016/j.jhep.2010.01.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
5 Chabert A, Hamzeh-Cognasse H, Pozzetto B, Cognasse F, Schattner M, Gomez RM, Garraud O. Human platelets and their capacity of binding viruses: meaning and challenges? BMC Immunol 2015;16:26. [PMID: 25913718 DOI: 10.1186/s12865-015-0092-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
6 Danish FA, Koul SS, Subhani FR, Rabbani AE, Yasmin S. Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag. Saudi J Gastroenterol 2010;16:51-6. [PMID: 20065578 DOI: 10.4103/1319-3767.58772] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
7 Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54:894-900. [PMID: 21145808 DOI: 10.1016/j.jhep.2010.08.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 6.4] [Reference Citation Analysis]
8 Chin JL, Hisamuddin SH, O'Sullivan A, Chan G, McCormick PA. Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation. Clin Appl Thromb Hemost 2016;22:351-60. [PMID: 25430936 DOI: 10.1177/1076029614559771] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
9 Fang T, Long G, Wang D, Liu X, Xiao L, Mi X, Su W, Zhou L, Zhou L. A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients. Front Oncol 2021;11:667496. [PMID: 34277414 DOI: 10.3389/fonc.2021.667496] [Reference Citation Analysis]
10 Moon DB, Lee SG, Hwang S, Ahn CS, Kim KH, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Cho HD, Kwon JH, Jung YK, Ha SM. Splenic devascularization can replace splenectomy during adult living donor liver transplantation - a historical cohort study. Transpl Int 2019;32:535-45. [PMID: 30714245 DOI: 10.1111/tri.13405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Djordjević J, Svorcan P, Vrinić D, Dapcević B. [Splenomegaly and thrombocytopenia in patients with liver cirrhosis]. Vojnosanit Pregl 2010;67:166-9. [PMID: 20337100 DOI: 10.2298/vsp1002166d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
12 Zhang JS, Cheng W, Li L. Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis: A case report. Medicine (Baltimore) 2017;96:e5843. [PMID: 28099341 DOI: 10.1097/MD.0000000000005843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ikezawa K, Naito M, Yumiba T, Iwahashi K, Onishi Y, Kita H, Nishio A, Kanno T, Matsuura T, Ono A. Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. J Viral Hepat. 2010;17:488-492. [PMID: 19840366 DOI: 10.1111/j.1365-2893.2009.01211.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
14 Barney EJ, Little EC, Gerkin RD, Ramos AX, Kahn J, Wong M, Kolli G, Manch R. Coated Transjugular Intrahepatic Portosystemic Shunt Does Not Improve Thrombocytopenia in Patients with Liver Cirrhosis. Dig Dis Sci 2012;57:2430-7. [DOI: 10.1007/s10620-012-2162-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Saray A, Mesihović R, Vukobrat-Bijedić Z, Gornjaković S, Vanis N, Mehmedović A, Papović V, Glavaš S. Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C. Bosn J Basic Med Sci 2013;13:84-8. [PMID: 23725503 DOI: 10.17305/bjbms.2013.2370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kosiorowska K, Lukaszewski M, Jakubaszko J, Kościelska-Kasprzak K, Bielicki G, Gozdzik W, Jasinski M. Platelets function assessment in patients qualified for cardiac surgery - clinical problems and a newer diagnostic possibilities. J Cardiothorac Surg 2018;13:131. [PMID: 30577843 DOI: 10.1186/s13019-018-0820-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Shi B, Zhu H, Liu Y, Lü L, Jin C, Ran L, Zhou K, Yang W, Wang Z, Mei Z. Experimental Studies and Clinical Experiences on Treatment of Secondary Hypersplenism with Extracorporeal High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology 2012;38:1911-7. [DOI: 10.1016/j.ultrasmedbio.2012.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Kato M, Shimohashi N, Ouchi J, Yoshida K, Tanabe Y, Takenaka K, Nakamuta M. Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism. J Gastroenterol. 2005;40:1076-1077. [PMID: 16322955 DOI: 10.1007/s00535-005-1693-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
19 Mao W, Sun Q, Fan J, Lin S, Ye B. AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis. Medicine (Baltimore) 2016;95:e2946. [PMID: 26945406 DOI: 10.1097/MD.0000000000002946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tang S, Huang Z, Jiang J, Gao J, Zhao C, Tai Y, Ma X, Zhang L, Ye Y, Gan C, Su W, Jia X, Liu R, Wu H, Tang C. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci 2021;272:119203. [PMID: 33577848 DOI: 10.1016/j.lfs.2021.119203] [Reference Citation Analysis]
21 Firat A, Boyvat F, Moray G, Aytekin C, Karakayali H, Haberal M. Comparison of two different percutaneous splenic artery interventions in the treatment of hypersplenism: preliminary report. Transplant Proc. 2005;37:1094-1098. [PMID: 15848633 DOI: 10.1016/j.transproceed.2004.12.171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
22 Huo Y, Liu J, Xu Z, Harrigan RL, Assad A, Abramson RG, Landman BA. Robust Multicontrast MRI Spleen Segmentation for Splenomegaly Using Multi-Atlas Segmentation. IEEE Trans Biomed Eng 2018;65:336-43. [PMID: 29364118 DOI: 10.1109/TBME.2017.2764752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
23 Choi WK, Kim J, Choi HJ, Hong SH, Chae MS. Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis: A case report. Medicine (Baltimore) 2021;100:e24298. [PMID: 33466218 DOI: 10.1097/MD.0000000000024298] [Reference Citation Analysis]
24 Afdhal NH, Esteban R. Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches. Aliment Pharmacol Ther 2007;26 Suppl 1:1-4. [PMID: 17958513 DOI: 10.1111/j.1365-2036.2007.03508.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
25 Huang HH, Lin HH, Shih YL, Chen PJ, Chang WK, Chu HC, Chao YC, Hsieh TY. Spontaneous intracranial hemorrhage in cirrhotic patients. Clin Neurol Neurosurg. 2008;110:253-258. [PMID: 18194837 DOI: 10.1016/j.clineuro.2007.11.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
26 Zhang Y, Zhang X. Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis. Cancer Manag Res 2018;10:3023-32. [PMID: 30214297 DOI: 10.2147/CMAR.S174095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Danish FI, Yasmin S. The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med 2013;5:17-30. [PMID: 24696622 DOI: 10.2147/HMER.S27100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Liu X, Chen Z, Yu M, Zhou W, Zhi X, Li T. Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis. Gastroenterol Res Pract 2019;2019:9065845. [PMID: 31485220 DOI: 10.1155/2019/9065845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
30 Mihăilă RG, Cipăian RC. Eltrombopag in chronic hepatitis C. World J Gastroenterol 2014; 20(35): 12517-12521 [PMID: 25253952 DOI: 10.3748/wjg.v20.i35.12517] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Leite LA, Pimenta Filho AA, Martins da Fonseca CS, Santana dos Santos B, Ferreira Rde C, Montenegro SM, Lopes EP, Domingues AL, Owen JS, Lima VL. Hemostatic dysfunction is increased in patients with hepatosplenic schistosomiasis mansoni and advanced periportal fibrosis. PLoS Negl Trop Dis 2013;7:e2314. [PMID: 23875049 DOI: 10.1371/journal.pntd.0002314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
32 Huo Y, Xu Z, Bao S, Bermudez C, Moon H, Parvathaneni P, Moyo TK, Savona MR, Assad A, Abramson RG, Landman BA. Splenomegaly Segmentation on Multi-Modal MRI Using Deep Convolutional Networks. IEEE Trans Med Imaging 2019;38:1185-96. [PMID: 30442602 DOI: 10.1109/TMI.2018.2881110] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
33 Onan E, Uskudar O, Coşkun Y, Akkiz H. Higher hepatitis C [correction of hepatis C ] virus concentration in platelets than in plasma in a patient with ITP. Platelets 2012;23:413-4. [PMID: 22010990 DOI: 10.3109/09537104.2011.625457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
35 Martins GLP, Bernardes JPG, Rovella MS, Andrade RG, Viana PCC, Herman P, Cerri GG, Menezes MR. Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option. World J Gastroenterol 2015; 21(20): 6391-6397 [PMID: 26034376 DOI: 10.3748/wjg.v21.i20.6391] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Wiklund RA. Preoperative preparation of patients with advanced liver disease. Crit Care Med 2004;32:S106-15. [PMID: 15064669 DOI: 10.1097/01.ccm.0000115624.13479.e6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
37 Rani GF, Preham O, Ashwin H, Brown N, Hitchcock IS, Kaye PM. Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis. Blood Adv 2021;5:1627-37. [PMID: 33710338 DOI: 10.1182/bloodadvances.2020004082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int. 2012;32:467-475. [PMID: 22098272 DOI: 10.1111/j.1478-3231.2011.02650.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
39 Xia D, Yang L, Li Y, Chen J, Zhang X, Wang H, Zhai S, Jiang X, Meca G, Wang S, Huang L, Zhu S, Fu Y, Ma W, Zhu Y, Ye H, Wang W. Melatonin alleviates Ochratoxin A-induced liver inflammation involved intestinal microbiota homeostasis and microbiota-independent manner. J Hazard Mater 2021;413:125239. [PMID: 33582472 DOI: 10.1016/j.jhazmat.2021.125239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, Chen J, Li LQ, Wu GB, Wu FX. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401-1414. [PMID: 30863151 DOI: 10.2147/cmar.s186114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
41 Leite LA, Domingues AL, Lopes EP, Ferreira Rde C, Pimenta Ade A Filho, da Fonseca CS, Dos Santos BS, Lima VL. Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis. Rev Bras Hematol Hemoter 2013;35:332-6. [PMID: 24255616 DOI: 10.5581/1516-8484.20130098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. ScientificWorldJournal 2014;2014:781857. [PMID: 24729754 DOI: 10.1155/2014/781857] [Cited by in Crossref: 128] [Cited by in F6Publishing: 110] [Article Influence: 18.3] [Reference Citation Analysis]
43 Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:5-11. [PMID: 17958514 DOI: 10.1111/j.1365-2036.2007.03510.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
44 Jiang HC, Sun B, Qiao HQ, Xu J, Piao DX, Yin H. Clinical application of serial operations with preserving spleen. World J Gastroenterol 2001; 7(6): 876-879 [PMID: 11854921 DOI: 10.3748/wjg.v7.i6.876] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
45 Zhang JS, Li L, Li Q, Cheng W. Laparoscopic splenic vessels ligation as a treatment of hypersplenism and thrombocytopenia in children. Surg Endosc 2016;30:3916-21. [PMID: 26659241 DOI: 10.1007/s00464-015-4698-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Danish FA, Koul SS, Subhani FR, Rabbani AE, Yasmin S. Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients. Saudi J Gastroenterol 2008;14:151-7. [PMID: 19568529 DOI: 10.4103/1319-3767.41739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
47 Ozturk O, Eldem G, Peynircioglu B, Kav T, Görmez A, Cil BE, Balkancı F, Sokmensuer C, Bayraktar Y. Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension. World J Gastroenterol 2016; 22(43): 9623-9630 [PMID: 27920483 DOI: 10.3748/wjg.v22.i43.9623] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
48 Alsufyani HA, McCormick PA, Docherty JR. Both α1B- and α1A-adrenoceptor subtypes are involved in contractions of rat spleen. Pharmacol Rep 2021;73:255-60. [PMID: 32860192 DOI: 10.1007/s43440-020-00118-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Iacobellis A, Andriulli A. Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection. Expert Opinion on Pharmacotherapy 2009;10:1929-38. [DOI: 10.1517/14656560903066811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
50 Yang HJ, Jiang JH, Yang YT, Guo Z, Li JJ, Liu XH, Lu F, Zeng FH, Ye JS, Zhang KL, Chen NZ, Xiang BD, Li LQ. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection. Tumour Biol 2017;39:1010428317695944. [PMID: 28351330 DOI: 10.1177/1010428317695944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Liu J, Xiao S, Wu S, Ou W, He J, Gao S, Liu Z. Disruption of splenic circulation using microbubble-enhanced ultrasound and prothrombin: a preliminary study. Ultrasound Med Biol 2012;38:1930-7. [PMID: 22929654 DOI: 10.1016/j.ultrasmedbio.2012.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Atance R, Pereira A, Ramirez B. Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion 2001;41:1548-52. [DOI: 10.1046/j.1537-2995.2001.41121548.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
53 Amin MA, El Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients. World J Surg 2009;33:1702-10. [DOI: 10.1007/s00268-009-0095-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
54 N’Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, Grando-Lemaire V, Ganne-Carrie N, Sellier N, Trinchet JC. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179-184. [PMID: 15674095 DOI: 10.1097/00042737-200502000-00008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 5.8] [Reference Citation Analysis]
55 Kabir T, Syn NL, Tan ZZX, Tan HJ, Yen C, Koh YX, Kam JH, Teo JY, Lee SY, Cheow PC, Chow PKH, Chung AYF, Ooi LL, Chan CY, Goh BKP. Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: A propensity-score matched and structural equation modelling study. Eur J Surg Oncol 2020;46:1756-65. [PMID: 32345496 DOI: 10.1016/j.ejso.2020.03.219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
56 Bruns F, Bremer M, Dettmer A, Janssen S. Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data. Radiat Oncol 2014;9:86. [PMID: 24673965 DOI: 10.1186/1748-717X-9-86] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
57 Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6(5): 160-168 [PMID: 24876920 DOI: 10.4329/wjr.v6.i5.160] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
58 Ito K, Akamatsu N, Ichida A, Ito D, Kaneko J, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Splenectomy is not indicated in living donor liver transplantation. Liver Transpl 2016;22:1526-35. [PMID: 27253521 DOI: 10.1002/lt.24489] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
59 Alzubiedi S, Saleh MI. Predictors of Severe Thrombocytopenia Secondary to Peginterferon Alfa-2a Treatment in Subjects With Hepatitis C Virus Infection. American Journal of Therapeutics 2017;24:e670-5. [DOI: 10.1097/mjt.0000000000000356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Abdella HM, Abd-El-Moez AT, Abu El-Maaty ME, Helmy AZ. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Indian J Gastroenterol. 2010;29:59-61. [PMID: 20443100 DOI: 10.1007/s12664-010-0013-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
61 Saleh MI, Obeidat AR, Anter HA, Khanfar AA. Eltrombopag dose predictors in thrombocytopenic subjects with hepatitis C virus infection. Clin Exp Pharmacol Physiol 2015;42:1030-5. [DOI: 10.1111/1440-1681.12451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
62 Wu Y, Jia G, Wang B, Xiong J, Xu J, Zheng P, Yuan Y, Li Y, Jiang T, Al Mamun A, Xu K, Liu Y, Cao H, Xiao J. Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress. Biochem Biophys Res Commun 2020;528:249-55. [PMID: 32482386 DOI: 10.1016/j.bbrc.2020.05.145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Wang D, Lu JG, Wang Q, Du XL, Dong R, Wang P, Zhao L, Jiang X, Yuan LJ. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension. Braz J Med Biol Res 2012;45:264-72. [PMID: 22267006 DOI: 10.1590/s0100-879x2012007500010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Chen CC, Chen SW, Tu PH, Huang YC, Liu ZH, Yi-Chou Wang A, Lee ST, Chen TH, Cheng CT, Wang SY, Chou AH. Outcomes of chronic subdural hematoma in patients with liver cirrhosis. J Neurosurg 2018;130:302-11. [PMID: 29393757 DOI: 10.3171/2017.8.JNS171103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Tang Y, Huo Y, Xiong Y, Moon H, Assad A, Moyo TK, Savona MR, Abramson R, Landman BA. Improving Splenomegaly Segmentation by Learning from Heterogeneous Multi-Source Labels. Proc SPIE Int Soc Opt Eng 2019;10949:1094908. [PMID: 31762532 DOI: 10.1117/12.2512842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
66 Chen CC, Hsu PW, Lee ST, Chang CN, Wei KC, Wu CT, Hsu YH, Lin TK, Lee SC, Huang YC. Brain surgery in patients with liver cirrhosis. J Neurosurg. 2012;117:348-353. [PMID: 22631693 DOI: 10.3171/2012.4.jns111338] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
67 Abo-Elenein AM, Mabrouk MM, Abou-Saif S, Saeed OM, Khodeir S, Elkadeem M, Elashry H, Haydara T, Zaghloul MS, Seleem WM, Elshweikh SA, Abd-Elsalam S. Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected Patients. Endocr Metab Immune Disord Drug Targets 2020;20:112-7. [PMID: 31142255 DOI: 10.2174/1871530319666190529092555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
68 Chen P, Tseng J, Lin Y, Wu YS, Hsiao Y, Chen J, Chen Y. Protective Effects of Functional Chicken Liver Hydrolysates against Liver Fibrogenesis: Antioxidation, Anti-inflammation, and Antifibrosis. J Agric Food Chem 2017;65:4961-9. [DOI: 10.1021/acs.jafc.7b01403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
69 Jiang B, Deng Q, Huo Y, Li W, Shibuya M, Luo J. Endothelial Gab1 deficiency aggravates splenomegaly in portal hypertension independent of angiogenesis. Am J Physiol Gastrointest Liver Physiol 2015;308:G416-26. [PMID: 25501549 DOI: 10.1152/ajpgi.00292.2014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection. Mediterr J Hematol Infect Dis. 2017;9:e2017019. [PMID: 28293407 DOI: 10.4084/mjhid.2017.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
71 Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S. Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia. Ther Clin Risk Manag 2019;15:269-74. [PMID: 30804674 DOI: 10.2147/TCRM.S186106] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Eissa LA, Gad LS, Rabie AM, El-gayar AM. Thrombopoietin level in patients with chronic liver diseases. Annals of Hepatology 2008;7:235-44. [DOI: 10.1016/s1665-2681(19)31854-x] [Cited by in Crossref: 15] [Article Influence: 1.2] [Reference Citation Analysis]
73 Deng H, Qi X, Peng Y, Li J, Li H, Zhang Y, Liu X, Sun X, Guo X. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit 2015;21:3961-77. [PMID: 26687574 DOI: 10.12659/msm.895005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
74 Senzolo M, Rodriguez K, Nadal E, Burra P. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916). Br J Surg. 2010;97:1452; author reply 1452-1453. [PMID: 20683871 DOI: 10.1002/bjs.7002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
75 Chen Y, Wang W, Wang H, Li Y, Shi M, Li H, Yan J. Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway. PLoS One. 2016;11:e0141159. [PMID: 26734934 DOI: 10.1371/journal.pone.0141159] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
76 Xia Z, Wang G, Wan C, Liu T, Wang S, Wang B, Cheng R. Expression of NALP3 in the spleen of mice with portal hypertension. J Huazhong Univ Sci Technolog Med Sci 2010;30:170-2. [PMID: 20407867 DOI: 10.1007/s11596-010-0207-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Aslanidou E, Fotoulaki M, Tsitouridis I, Nousia-arvanitakis S. Partial Splenic Embolization: Successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis. Journal of Cystic Fibrosis 2007;6:212-4. [DOI: 10.1016/j.jcf.2006.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]